跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
诺和灵N - NMPA Drug Approval Details
Approvals
/
NMPA
/
Isophane Protamine Human Insulin Injection
Approved
生物制品
Isophane Protamine Human Insulin Injection
Novo Nordisk A/S
🇨🇳 National Medical Products Administration
Approval Date
Oct 14, 2022
Approval ID
33e21f9ffed3eb42
Company
Novo Nordisk A/S
Type
生物制品
Approval Details
Approval Id
33e21f9ffed3eb42
Approval Number
国药准字SJ20201017
Generic Name
精蛋白生物合成人胰岛素注射液
Generic Name En
Isophane Protamine Human Insulin Injection
Trade Name
诺和灵N
Drug Type
生物制品
Dosage Form
注射剂
Strength
300IU/3ml/支(笔芯)
Reg Date
2022-10-14
Expired Date
2027-10-13
Company Name
Novo Nordisk A/S
Production Company Name
Novo Nordisk A/S
Company Detail Path
/organization/novo-nordisk-a-s
Production Company Detail Path
/organization/novo-nordisk-a-s
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Oct 14, 2022
Approval ID
33e21f9ffed3eb42
Type
生物制品
Back to NMPA Approvals
